- Home
- RVMD vs CRL Comparison
RVMD vs CRL Comparison
Compare RVMD & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVMD | CRL |
|---|---|---|
| Founded | 2014 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 8.3B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | RVMD | CRL |
|---|---|---|
| Price | $98.94 | $152.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 13 |
| Target Price | $114.63 | ★ $197.58 |
| AVG Volume (30 Days) | ★ 1.6M | 1.1M |
| Earning Date | 01-01-0001 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,857,601,000.00 |
| Revenue This Year | N/A | $2.11 |
| Revenue Next Year | $454.85 | $2.95 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.48 |
| 52 Week Low | $29.17 | $91.86 |
| 52 Week High | $124.49 | $228.88 |
Technical Indicators
Market Signals| Indicator | RVMD | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 49.47 | 32.92 |
| Support Level | $93.59 | $145.97 |
| Resistance Level | $107.45 | $157.42 |
| Average True Range (ATR) | 3.89 | 6.86 |
| MACD | -0.58 | -1.08 |
| Stochastic Oscillator | 33.33 | 4.06 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.